The $538 million acquisition by Luye Pharma Group Ltd. (HKSE:2186) of Seroquel quetiapine fumarate from AstraZeneca plc (LSE: AZN; NYSE: AZN) will lay the commercial groundwork in new emerging markets for the Chinese pharma's internal CNS pipeline.